Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure.

McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT.

Pediatr Blood Cancer. 2012 Jun;58(6):945-9. doi: 10.1002/pbc.23259. Epub 2011 Jul 25.

2.

Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.

Payne AB, Link-Gelles R, Azonobi I, Hooper WC, Beall BW, Jorgensen JH, Juni B, Moore M; Active Bacterial Core Surveillance Team.

Pediatr Infect Dis J. 2013 Dec;32(12):1308-12. doi: 10.1097/INF.0b013e3182a11808.

3.

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

Halasa NB, Shankar SM, Talbot TR, Arbogast PG, Mitchel EF, Wang WC, Schaffner W, Craig AS, Griffin MR.

Clin Infect Dis. 2007 Jun 1;44(11):1428-33. Epub 2007 Apr 18.

PMID:
17479937
4.

National trends in incidence rates of hospitalization for stroke in children with sickle cell disease.

McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT.

Pediatr Blood Cancer. 2013 May;60(5):823-7. doi: 10.1002/pbc.24392. Epub 2012 Nov 14.

5.

Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era.

Martin OO, Moquist KL, Hennessy JM, Nelson SC.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26713. Epub 2017 Jul 4.

PMID:
28675587
6.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
7.

Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):253-7.

8.

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.

Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W.

JAMA. 2006 Apr 12;295(14):1668-74.

PMID:
16609088
9.
10.

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.

Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J; Massachusetts Department of Public Health Epidemiologists.

Pediatr Infect Dis J. 2005 Jan;24(1):17-23.

PMID:
15665705
11.

Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020.

Link-Gelles R, Taylor T, Moore MR; Active Bacterial Core Surveillance Team.

Vaccine. 2013 May 24;31(22):2572-7. doi: 10.1016/j.vaccine.2013.03.049. Epub 2013 Apr 11.

PMID:
23583813
12.

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

Rudnick W, Liu Z, Shigayeva A, Low DE, Green K, Plevneshi A, Devlin R, Downey J, Katz K, Kitai I, Krajden S, Ostrowska K, Richardson D, Richardson S, Sarabia A, Silverman M, Simor AE, Tyrrell G, McGeer A; Toronto Invasive Bacterial Diseases Network.

Vaccine. 2013 Dec 2;31(49):5863-71. doi: 10.1016/j.vaccine.2013.09.049. Epub 2013 Oct 5.

PMID:
24099873
14.

Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.

Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, Rolo D, Grau I, Martín R, Liñares J.

Clin Infect Dis. 2009 Jan 1;48(1):57-64. doi: 10.1086/594125.

PMID:
19035779
15.

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT.

Clin Infect Dis. 2005 Jul 1;41(1):21-9. Epub 2005 May 26.

PMID:
15937758
16.

Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.

Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W.

Pediatr Infect Dis J. 2013 Jun;32(6):604-9. doi: 10.1097/INF.0b013e318287fe0d.

PMID:
23348816
17.

Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine.

Winther TN, Kristensen TD, Kaltoft MS, Konradsen HB, Knudsen JD, Høgh B.

Acta Paediatr. 2009 Feb;98(2):328-31. doi: 10.1111/j.1651-2227.2008.01080.x. Epub 2008 Oct 24.

PMID:
18983440
18.

The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.

Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL.

Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72.

19.

Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.

Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, García-de-Miguel MJ, Hernández-Sampelayo T, Otheo E, Méndez C; Heracles Study Group.

Pediatr Infect Dis J. 2013 Jun;32(6):656-61. doi: 10.1097/INF.0b013e31827e8594.

PMID:
23249906
20.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490

Supplemental Content

Support Center